Yabin Liu

Yabin Liu

Auto-generated profile, based on publicly available information

Yabin Liu

Department of Endocrinology, Fourth Affiliated Hospital, Hebei Medical University, Shijiazhuang, China

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Nucleic Acids Research
Verified
Journal Article
Open access
PKPeng Kong
Peng Kong
YYYuan Yu
Yuan Yu
LWLu Wang
Lu Wang
YDYong-Qing Dou
Yong-Qing Dou
XZXu-Hui Zhang
Xu-Hui Zhang
MHMei Han
Mei Han
NF-κB-mediated inflammatory phenotypic switching of vascular smooth muscle cells (VSMCs) plays a central role in atherosclerosis and neointimal formation. However, little is known about the roles of circRNAs in the regulation of NF-κB signaling. Here, we identify the involvement of circ-Sirt1 that was one of transcripts of SIRT1 host gene in VSMC inflammatory response and neointimal hyperplasia. First, in the cytoplasm, circ-Sirt1 directly interacts with and sequesters NF-κB p65 from nuclear translocation induced by TNF-α in a sequence-dependent manner. The inhibitory complex of circ-Sirt1-NF-κB p65 is not dependent on IκBα. Second, circ-Sirt1 binds to miR-132/212 that interferes with SIRT1 mRNA, and facilitates the expression of host gene SIRT1. Increased SIRT1 results in deacetylation and inactivation of the nuclear NF-κB p65. These findings illustrate that circ-Sirt1 is a novel non-coding RNA regulator of VSMC phenotype.

1 January 2019 in Technology in Cancer Research & Treatment
Verified
Journal Article
Open access
PDF file
TBTianliang Bai
Tianliang Bai
YZYalei Zhao
Yalei Zhao
YLYabin Liu
Yabin Liu
BCBindan Cai
Bindan Cai
NDNing Dong
Ning Dong
BLBinghui Li
Binghui Li
To identify the expression of kinetochore scaffold 1 (KNL1) in colorectal tumor tissues and to clarify the role of this gene in the proliferation capability of colorectal cancer cells. A total of 108 paired colorectal tumor and normal tissue samples were collected from patients with colorectal cancer and subjected to quantitative polymerase chain reaction and immunohistochemistry analyses. Expression levels of KNL1 mRNA and protein were compared between tumor and normal tissues, and KNL1 levels were evaluated in relation to the patients’ tumor differentiation, sex, lymph node metastasis, TNM stage, infiltration depth, age, and tumor location. Survival curves were also constructed and compared between patients with tumor samples with and without KLN1 protein expression. KNL1 was under-expressed in colorectal cancer cells in vitro using lentiviral transfection with short hairpin RNA, and its function was evaluated by proliferation, colony-formation, and apoptosis assays. Expression levels of BUB1 protein were also compared between tumor and normal tissues, and the correlation between KNL1 expression and BUB1 expression in colorectal cancer tissues was examined. KNL1 mRNA and protein were both highly expressed in colorectal tumor tissues compared with paired normal tissues. KNL1 downregulation significantly inhibited colorectal cancer cell proliferation and colony formation, and promoted apoptosis. KNL1 protein expression was significantly associated with tumor differentiation, but not with sex, lymph node metastasis, TNM stage, infiltration depth, age, or tumor location. KNL1 protein expression was also significantly associated with poorer survival. Moreover, there was a significant correlation between KNL1 and BUB1 in colorectal cancer tissues. KNL1 plays an effective role in decreasing apoptosis and promoting the proliferation of colorectal cancer cells, suggesting that its inhibition may represent a promising therapeutic approach in patients with colorectal cancer.

13 October 2009 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
QWQing-Lei Wang
Qing-Lei Wang
BLBinghui Li
Binghui Li
BLBin Liu
Bin Liu
YLYa-Bin Liu
Ya-Bin Liu
YLYue-Ping Liu
Yue-Ping Liu
MHMei Han
Mei Han
Genetic factors are thought to play a role in development for colorectal carcinogenesis. ICAM-1 is a polymorphic gene, thus, the present study investigated the relationship between the polymorphisms of ICAM-1 and the susceptibility and phenotypical characteristics of colorectal cancer (CRC). The polymorphisms at ICAM-1 exon 4 (G241R) and exon 6 (E469K) were detected by PCR with sequence-specific primers. The relationship between specific genotypes of ICAM-1 and differentiation of CRC was evaluated by the histological grade. We showed only GG genotype of ICAM-1 individuals in either CRC or normal controls. The KK genotype of ICAM-1 K469E was found more frequently than in the controls (P < 0.05). Patients with well-differentiated CRC displayed the KK more frequently than those of poor differentiation (P < 0.05). The findings indicate that polymorphisms of G241R are rare in Chinese population and that KK genotype of ICAM-1 K469E is significantly associated with well differentiation of CRC.

2 August 2011 in Oncology Reports
Verified
Journal Article
Open access
PDF file
BLBinghui Li
Binghui Li
XFXin-Mei Fang
Xin-Mei Fang
BLBin Liu
Bin Liu
YLYa-Bin Liu
Ya-Bin Liu
JWJun-Jie Wang
Jun-Jie Wang
MHMei Han
Mei Han
Acetylbritannilactone (ABL) is a new active compound isolated from Inula Britannica L, a traditional Chinese medicinal herb. It has been reported that ABL can inhibit the proliferation of vascular smooth muscle cells (VSMCs) and neointima formation after balloon injury in rats. ABL also shows chemopreventive properties by inducing cell apoptosis in breast and ovarian cancers, but the antitumor activity and the molecular targets of ABL in colon cancer cells have not been determined. In this study, we showed that ABL inhibits the growth in dose- and time-dependent manners by inducing cell cycle arrest in G0/G1 phase of HT-29 human colon cancer cells. This suppression was accompanied by a strong decrease of cyclin E and CDK4 protein levels, and an increase in p21 protein expression in HT-29 cells. We also show that ABL-induced growth inhibition is associated with the upregulation of KLF4 expression. The overexpression of KLF4 by infection with pAd-KLF4 resulted in growth inhibition, with decrease in the protein levels of cyclin E and CDK4, and increase in the expression of p21, similarly to the effects of ABL. Conversely, knockdown of KLF4 using a specific siRNA impaired the ABL-induced growth inhibition in HT-29 cells. These results suggest that KLF4 as an important cellular target of ABL mediates the growth inhibition of HT-29 cells induced by ABL via upregulation of p21 expression.

20 June 2018 in Oncology Letters
Verified
Journal Article
Open access
PDF file
LJLining Jiang
Lining Jiang
YLYabin Liu
Yabin Liu
CMCan Ma
Can Ma
BLBinghui Li
Binghui Li
An increasing number of studies reported that microRNA (miR)‑30a was dysregulated in several types of human cancer and may contribute to cancer carcinogenesis and progression. However, its expression and roles in renal cell carcinoma (RCC) remain unknown. In the present study, reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) was performed to quantify miR‑30a expression in RCC tissues and cell lines. The cell counting kit‑8 assay, migration and invasion assays were used to evaluate the roles of miR‑30a on the proliferation, migration and invasion of RCC cells. The target gene of miR‑30a was identified by luciferase reporter assays, RT‑qPCR and western blotting. The results indicated that miR‑30a was downregulated in RCC tissues and cell lines compared with corresponding noncancerous tissues and normal renal cell line, respectively. Re‑expression of miR‑30a inhibited the proliferation, migration and invasion of RCC cells. Additionally, ADAM metallopeptidase domain 9 (ADAM9) was validated as a direct target of miR‑30a. Furthermore, the knockdown of ADAM9 by small interfering RNAs was able to mimic the effects of miR‑30a overexpression in RCC cells. These results highlight the important role for miR‑30a in the occurrence and development of RCC, and the restoration of miR‑30a might be investigated as a potential strategy for treating RCC.

13 March 2013 in Pathology - Research and Practice
Verified
Journal Article
Closed access
XXXiao-Li Xie
Xiao-Li Xie
YLYa-Bin Liu
Ya-Bin Liu
YLYue-Ping Liu
Yue-Ping Liu
BDBin-Liang Du
Bin-Liang Du
YLYang Li
Yang Li
BLBinghui Li
Binghui Li